Tapclob 5mg/5ml oral suspension
BNF presentation 040801060BDAACR within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
040801060BDAACR
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
406
NHS spend (£)
£95,664.40
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 9 |
| December 2024 | 6 |
| November 2024 | 20 |
| October 2024 | 15 |
| July 2024 | 21 |
| May 2024 | 5 |
| July 2021 | 47 |
| June 2021 | 36 |
| December 2020 | 111 |
| November 2020 | 136 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
|
Beacon Medical Group
ODS L83100
|
5 | 15N - DEVON ICB |
| Unknown pharmacy | 5 | No data available |